Targeting MAPK Signaling: Loureirins A and B from <i>Dracaena Loureiri</i> Inhibit Epithelial–Mesenchymal Transition and Invasion in Non-Small Cell Lung Cancer Cell Lines
Metastasis remains the leading cause of death among patients with non-small cell lung cancer (NSCLC), emphasizing the urgent need for safer and more effective therapeutic options. Mitogen-activated protein kinase (MAPK) pathways play a crucial role in regulating EMT, migration, and invasion in NSCLC...
Saved in:
| Main Authors: | Xiaomin Huang, Punnida Arjsri, Kamonwan Srisawad, Sonthaya Umsumarng, Supachai Yodkeeree, Pornngarm Dejkriengkraikul |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/15/3/396 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Luteolin-Rich Extract from <i>Harrisonia perforata</i> (Blanco) Merr. Root Alleviates SARS-CoV-2 Spike Protein-Stimulated Lung Inflammation via Inhibition of MAPK/NLRP3 Inflammasome Signaling Pathways
by: Warathit Semmarath, et al.
Published: (2025-07-01) -
MiR‐766‐3p Inhibit the Proliferation, Stemness, and Cell Cycle of Pancreatic Cancer Cells Through the MAPK/ERK Signaling Pathway
by: Zhipeng Quan, et al.
Published: (2024-12-01) -
LMAN2 Promotes Breast Cancer Tumorigenesis and Drug Resistance by Interacting With MAPK9 via Activation of the MAPK Pathway
by: Chen Feng, et al.
Published: (2024-12-01) -
The Cholesterol Biosynthesis Pathway Plays an Important Role in Chemotherapeutic Drug Response and Metastasis in High-Grade Osteosarcoma
by: Amonnat Sukhamwang, et al.
Published: (2025-06-01) -
ZEB1‐mediated melanoma cell plasticity enhances resistance to MAPK inhibitors
by: Geoffrey Richard, et al.
Published: (2016-09-01)